RxDoctor Payments Data

Andrew von Eschenbach

Urology · Montgomery, TXNPI 1942540190

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $2,123,496 of the $3,230,611 with a category attached, or 65.7%. 6 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 41.2% of the total. Among urology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,230,611in general payments, 2019–2025

Across 210 payments — averaging $15,384 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$1.3M
  • Bausch Health US, LLC$814K
  • Radius Health, Inc.$516K
  • Celularity Inc.$380K
  • Chugai Pharmaceutical Co., Ltd.$143K
  • Trisalus Life Sciences, Inc.$48K

What the payments were for

  • Consulting fees$775,49324%
  • Speaking & faculty fees$2,123,49666%
  • Travel & lodging$60,9962%
  • Food & beverage$7,5490%
  • Gifts$770%
  • Ownership interest$263,0008%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,230,611 in reported general payments places this provider in the 95th percentile of 878 urology providers in Texas.

See all urology providers in Texas

Other urology in Montgomery

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →